Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,848 | 245 | 89.3% |
| Education | $579.67 | 11 | 10.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,172 | 51 | $0 (2022) |
| Boston Scientific Corporation | $854.98 | 19 | $0 (2023) |
| Janssen Biotech, Inc. | $431.01 | 19 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $369.89 | 22 | $0 (2022) |
| ABBVIE INC. | $333.76 | 19 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $280.57 | 17 | $0 (2022) |
| Amgen Inc. | $255.46 | 15 | $0 (2022) |
| Coloplast Corp | $217.56 | 14 | $0 (2022) |
| PFIZER INC. | $210.58 | 11 | $0 (2022) |
| C. R. BARD, INC. & SUBSIDIARIES | $172.48 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $109.49 | 3 | Boston Scientific Corporation ($109.49) |
| 2022 | $701.47 | 39 | Bayer HealthCare Pharmaceuticals Inc. ($121.11) |
| 2021 | $2,439 | 121 | Astellas Pharma US Inc ($514.08) |
| 2020 | $698.05 | 29 | Astellas Pharma US Inc ($283.42) |
| 2019 | $637.77 | 27 | C. R. BARD, INC. & SUBSIDIARIES ($172.48) |
| 2018 | $689.64 | 28 | Boston Scientific Corporation ($307.45) |
| 2017 | $152.04 | 9 | BOSTON SCIENTIFIC CORPORATION ($72.75) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $38.60 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 07/19/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $36.34 | General |
| Category: LithoVue_URO | ||||||
| 07/19/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: LithoVue_URO | ||||||
| 06/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Oncology | ||||||
| 05/26/2022 | Cook Medical LLC | HIWIRE (Device) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Urology | ||||||
| 05/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Oncology | ||||||
| 05/20/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/11/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Urology | ||||||
| 04/29/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/28/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Urology | ||||||
| 04/22/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/21/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Oncology | ||||||
| 04/15/2022 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Oncology | ||||||
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Oncology | ||||||
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Education | In-kind items and services | $8.15 | General |
| Category: Oncology | ||||||
| 03/29/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Prostate Cancer | ||||||
| 03/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/23/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Oncology | ||||||
| 03/22/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Oncology | ||||||
| 03/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Urology | ||||||
| 03/07/2022 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 03/04/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Urology | ||||||
| 03/03/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/24/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,363 | 2,645 | $444,338 | $139,777 |
| 2022 | 10 | 335 | 415 | $60,154 | $14,309 |
| 2021 | 24 | 1,171 | 4,845 | $272,976 | $82,224 |
| 2020 | 13 | 444 | 555 | $74,711 | $23,697 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 300 | $71,482 | $32,626 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 110 | 137 | $39,593 | $20,726 | 52.3% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 28 | 28 | $112,085 | $16,250 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $38,640 | $15,371 | 39.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 65 | 66 | $27,984 | $13,674 | 48.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $17,220 | $7,890 | 45.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 67 | 100 | $22,300 | $5,426 | 24.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 32 | 33 | $7,854 | $3,440 | 43.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 176 | 300 | $30,600 | $2,920 | 9.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $5,400 | $2,758 | 51.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 14 | 34 | $7,718 | $2,632 | 34.1% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 18 | 24 | $6,840 | $2,497 | 36.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 31 | 35 | $6,090 | $1,973 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 28 | $4,015 | $1,865 | 46.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,376 | $1,680 | 38.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 14 | $16,803 | $1,566 | 9.3% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 14 | 610 | $3,660 | $1,380 | 37.7% |
| 51705 | Simple change of bladder tube | Office | 2023 | 14 | 14 | $2,674 | $1,204 | 45.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 273 | 545 | $4,088 | $1,195 | 29.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 15 | $2,250 | $1,096 | 48.7% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 16 | 25 | $925.00 | $516.98 | 55.9% |
| 74485 | Review by radiologist of ureter or urethra image | Facility | 2023 | 11 | 14 | $1,638 | $464.94 | 28.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 11 | 13 | $936.00 | $354.53 | 37.9% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 39 | 40 | $9,040 | $242.80 | 2.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 64 | $128.00 | $26.56 | 20.8% |
About Dr. Jon Soble, MD
Dr. Jon Soble, MD is a Urology healthcare provider based in Tallahassee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487639969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Soble, MD has received a total of $5,427 in payments from pharmaceutical and medical device companies, with $109.49 received in 2023. These payments were reported across 256 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,848).
As a Medicare-enrolled provider, Soble has provided services to 3,313 Medicare beneficiaries, totaling 8,460 services with total Medicare billing of $260,006. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Tallahassee, FL
- Active Since 12/07/2005
- Last Updated 10/09/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487639969
Products in Payments
- XTANDI (Drug) $495.21
- XIAFLEX (Biological) $357.14
- ERLEADA (Drug) $353.53
- MYRBETRIQ (Drug) $342.47
- LITHOVUE (Device) $335.12
- Nubeqa (Drug) $216.28
- SpeediCath (Device) $199.07
- BOTOX (Biological) $194.68
- LUPRON DEPOT (Drug) $182.23
- ELIGARD (Drug) $153.07
- Prolaris (Device) $137.98
- GENERAL THERAPIES (Device) $129.30
- XGEVA (Biological) $128.45
- PROVENGE (Drug) $127.86
- Prolia (Biological) $89.70
- GENERAL ERECTILE DYSFUNCTION (Device) $82.27
- Erleada (Drug) $77.48
- Myrbetriq (Drug) $74.31
- LithoVue (Device) $70.89
- Xofigo (Drug) $64.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Tallahassee
Dr. Scott Sellinger, Md, MD
Urology — Payments: $2.1M
Dr. Jean-Paul Tran, Md, MD
Urology — Payments: $23,918
Dr. Robert Bradford, Md, MD
Urology — Payments: $17,195
Dr. Joseph Camps, Md, MD
Urology — Payments: $9,784
Jamey Sarvis
Urology — Payments: $9,765
Dr. Christopher Murphy, D.o, D.O
Urology — Payments: $9,130